3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development

Multimodality 3D Optical Imaging (OI)/CT has the potential to play a major role in drug development for glioblastomas (GBM), as it is an accessible preclinical method. To demonstrate the potential of 3D OI/CT to visualize orthotopic GBM implantation, we labeled GBM cells with Cy7 and imaged their lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Molotkov, Andrei, Doubrovin, Mikhail, Bhatt, Nikunj, Hsu, Fang-Chi, Beserra, Amanda, Chopra, Rajiv, Mintz, Akiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717859/
https://www.ncbi.nlm.nih.gov/pubmed/33263448
http://dx.doi.org/10.1080/10717544.2020.1833381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717859/
https://www.ncbi.nlm.nih.gov/pubmed/33263448
http://dx.doi.org/10.1080/10717544.2020.1833381

Ejemplares similares